117 related articles for article (PubMed ID: 26541871)
1. Reduction in sphingosine kinase 1 influences the susceptibility to dengue virus infection by altering antiviral responses.
Clarke JN; Davies LK; Calvert JK; Gliddon BL; Shujari WHA; Aloia AL; Helbig KJ; Beard MR; Pitson SM; Carr JM
J Gen Virol; 2016 Jan; 97(1):95-109. PubMed ID: 26541871
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo roles of sphingosine kinase 2 during dengue virus infection.
Al-Shujairi WH; Clarke JN; Davies LT; Pitman MR; Calvert JK; Aloia AL; Pitson SM; Carr JM
J Gen Virol; 2019 Apr; 100(4):629-641. PubMed ID: 30869582
[TBL] [Abstract][Full Text] [Related]
3. Intracranial Injection of Dengue Virus Induces Interferon Stimulated Genes and CD8+ T Cell Infiltration by Sphingosine Kinase 1 Independent Pathways.
Al-Shujairi WH; Clarke JN; Davies LT; Alsharifi M; Pitson SM; Carr JM
PLoS One; 2017; 12(1):e0169814. PubMed ID: 28095439
[TBL] [Abstract][Full Text] [Related]
4. Viperin is anti-viral
Al Shujairi WH; Kris LP; van der Hoek K; Cowell E; Bracho-Granado G; Woodgate T; Beard MR; Carr JM
J Gen Virol; 2021 Oct; 102(10):. PubMed ID: 34665110
[TBL] [Abstract][Full Text] [Related]
5. Investigation of sphingosine kinase 1 in interferon responses during dengue virus infection.
Aloia AL; Calvert JK; Clarke JN; Davies LT; Helbig KJ; Pitson SM; Carr JM
Clin Transl Immunology; 2017 Jul; 6(7):e151. PubMed ID: 28791126
[TBL] [Abstract][Full Text] [Related]
6. The roles of IRF-3 and IRF-7 in innate antiviral immunity against dengue virus.
Chen HW; King K; Tu J; Sanchez M; Luster AD; Shresta S
J Immunol; 2013 Oct; 191(8):4194-201. PubMed ID: 24043884
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility and initial immune response of Tupaia belangeri cells to dengue virus infection.
Kayesh MEH; Kitab B; Sanada T; Hayasaka D; Morita K; Kohara M; Tsukiyama-Kohara K
Infect Genet Evol; 2017 Jul; 51():203-210. PubMed ID: 28392469
[TBL] [Abstract][Full Text] [Related]
8. Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses.
Surasombatpattana P; Hamel R; Patramool S; Luplertlop N; Thomas F; Desprès P; Briant L; Yssel H; Missé D
Infect Genet Evol; 2011 Oct; 11(7):1664-73. PubMed ID: 21722754
[TBL] [Abstract][Full Text] [Related]
9. Dengue Virus Infection of Primary Endothelial Cells Induces Innate Immune Responses, Changes in Endothelial Cells Function and Is Restricted by Interferon-Stimulated Responses.
Calvert JK; Helbig KJ; Dimasi D; Cockshell M; Beard MR; Pitson SM; Bonder CS; Carr JM
J Interferon Cytokine Res; 2015 Aug; 35(8):654-65. PubMed ID: 25902155
[TBL] [Abstract][Full Text] [Related]
10. Reduced sphingosine kinase 1 activity in dengue virus type-2 infected cells can be mediated by the 3' untranslated region of dengue virus type-2 RNA.
Carr JM; Kua T; Clarke JN; Calvert JK; Zebol JR; Beard MR; Pitson SM
J Gen Virol; 2013 Nov; 94(Pt 11):2437-2448. PubMed ID: 23939980
[TBL] [Abstract][Full Text] [Related]
11. Interferon lambda inhibits dengue virus replication in epithelial cells.
Palma-Ocampo HK; Flores-Alonso JC; Vallejo-Ruiz V; Reyes-Leyva J; Flores-Mendoza L; Herrera-Camacho I; Rosas-Murrieta NH; Santos-López G
Virol J; 2015 Sep; 12():150. PubMed ID: 26411318
[TBL] [Abstract][Full Text] [Related]
12. Tumour necrosis factor alpha (TNF-alpha) stimulation of cells with established dengue virus type 2 infection induces cell death that is accompanied by a reduced ability of TNF-alpha to activate nuclear factor kappaB and reduced sphingosine kinase-1 activity.
Wati S; Rawlinson SM; Ivanov RA; Dorstyn L; Beard MR; Jans DA; Pitson SM; Burrell CJ; Li P; Carr JM
J Gen Virol; 2011 Apr; 92(Pt 4):807-18. PubMed ID: 21148274
[TBL] [Abstract][Full Text] [Related]
13.
Balinsky CA; Schmeisser H; Wells AI; Ganesan S; Jin T; Singh K; Zoon KC
J Virol; 2017 Mar; 91(5):. PubMed ID: 27974568
[TBL] [Abstract][Full Text] [Related]
14. Activation of the innate immune response against DENV in normal non-transformed human fibroblasts.
Bustos-Arriaga J; García-Machorro J; León-Juárez M; García-Cordero J; Santos-Argumedo L; Flores-Romo L; Méndez-Cruz AR; Juárez-Delgado FJ; Cedillo-Barrón L
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1420. PubMed ID: 22206025
[TBL] [Abstract][Full Text] [Related]
15. Human keratinocyte cultures (HaCaT) can be infected by DENV, triggering innate immune responses that include IFNλ and LL37.
López-González M; Meza-Sánchez D; García-Cordero J; Bustos-Arriaga J; Vélez-Del Valle C; Marsch-Moreno M; Castro-Jiménez T; Flores-Romo L; Santos-Argumedo L; Gutiérrez-Castañeda B; Cedillo-Barrón L
Immunobiology; 2018 Nov; 223(11):608-617. PubMed ID: 30007822
[TBL] [Abstract][Full Text] [Related]
16. Resistance to dengue virus infection in mice is potentiated by CXCL10 and is independent of CXCL10-mediated leukocyte recruitment.
Ip PP; Liao F
J Immunol; 2010 May; 184(10):5705-14. PubMed ID: 20400703
[TBL] [Abstract][Full Text] [Related]
17. DDX50 inhibits the replication of dengue virus 2 by upregulating IFN-β production.
Han P; Ye W; Lv X; Ma H; Weng D; Dong Y; Cheng L; Chen H; Zhang L; Xu Z; Lei Y; Zhang F
Arch Virol; 2017 Jun; 162(6):1487-1494. PubMed ID: 28181036
[TBL] [Abstract][Full Text] [Related]
18. Characterization of RyDEN (C19orf66) as an Interferon-Stimulated Cellular Inhibitor against Dengue Virus Replication.
Suzuki Y; Chin WX; Han Q; Ichiyama K; Lee CH; Eyo ZW; Ebina H; Takahashi H; Takahashi C; Tan BH; Hishiki T; Ohba K; Matsuyama T; Koyanagi Y; Tan YJ; Sawasaki T; Chu JJ; Vasudevan SG; Sano K; Yamamoto N
PLoS Pathog; 2016 Jan; 12(1):e1005357. PubMed ID: 26735137
[TBL] [Abstract][Full Text] [Related]
19. A MicroRNA Screen Identifies the Wnt Signaling Pathway as a Regulator of the Interferon Response during Flavivirus Infection.
Smith JL; Jeng S; McWeeney SK; Hirsch AJ
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148804
[TBL] [Abstract][Full Text] [Related]
20. Induction of anti-viral genes mediated by humoral factors upon stimulation with Lactococcus lactis strain plasma results in repression of dengue virus replication in vitro.
Tsuji R; Yamamoto N; Yamada S; Fujii T; Yamamoto N; Kanauchi O
Antiviral Res; 2018 Dec; 160():101-108. PubMed ID: 30393011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
